Vaginal bleeding disturbances and implantable contraceptives

被引:37
作者
Hickey, M [1 ]
d'Arcangues, C
机构
[1] Univ London Imperial Coll Sci & Technol, Sch Med, Dept Reprod Sci & Med, London W2 1PG, England
[2] UNDP, UNFPA, World Bank, WHO Special Programme Res Dev & Res Training Huma, Geneva, Switzerland
关键词
contraceptive; implant; progestogen; breakthrough bleeding;
D O I
10.1016/S0010-7824(01)00292-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Implantable contraceptives allow safe and effective fertility regulation for up to 5 years. Currently available devices release low doses of progestogens. Disruption of vaginal bleeding patterns is almost inevitable, particularly during the initial months of use. Irregular and prolonged bleeding as well as amenorrhea are common. Irregular bleeding is unpopular with most women and unacceptable to some. This review describes the vaginal bleeding disturbances induced by modern implantable contraceptives and discusses the implications of these in terms of method use and discontinuations. The cause of the irregular bleeding is not fully understood, but recent evidence suggests that an increase in endometrial vascular fragility might precipitate vessel break-down and, hence, breakthrough bleeding. This review discusses this evidence and outline the possible mechanisms underlying breakthrough bleeding associated with implantable contraceptives. In addition, therapies for bleeding disturbances are described and their efficacy reviewed. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 91 条
[1]   RETRACTED: An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon® (Retracted Article) [J].
Affandi, B .
CONTRACEPTION, 1998, 58 (06) :99S-107S
[2]   Prolonged hypoxia alters endothelial barrier function [J].
Ali, MH ;
Schlidt, SA ;
Hynes, HL ;
Marcus, BC ;
Gewertz, BL .
SURGERY, 1998, 124 (03) :491-497
[3]   Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel [J].
Cheng, L ;
Zhu, H ;
Wang, A ;
Ren, F ;
Chen, J ;
Glasier, A .
HUMAN REPRODUCTION, 2000, 15 (09) :1969-1972
[4]  
CHRISTIAENS GCM, 1982, AM J REPROD IMMUNOL, V5, P78
[5]   Role of nitric oxide in implantation and menstruation [J].
Chwalisz, K ;
Garfield, RE .
HUMAN REPRODUCTION, 2000, 15 :96-111
[6]  
Clark DA, 1996, HUM REPROD, V11, P1438
[7]   Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant [J].
Coutinho, EM ;
deSouza, JC ;
Athayde, C ;
Barbosa, IC ;
Alvarez, F ;
Brache, V ;
Gu, ZP ;
Emuveyan, EE ;
Adekunle, AO ;
Devoto, L ;
Shaaban, MM ;
Salem, HT ;
Affandi, B ;
deAcosta, OM ;
Mati, J ;
Ladipo, OA .
CONTRACEPTION, 1996, 53 (02) :121-125
[8]   IMMUNOHISTOCHEMICAL SEX STEROID-RECEPTOR DISTRIBUTION IN ENDOMETRIUM FROM LONG-TERM SUBDERMAL LEVONORGESTREL USERS AND DURING THE NORMAL MENSTRUAL-CYCLE [J].
CRITCHLEY, HOD ;
BAILEY, DA ;
AU, CL ;
AFFANDI, B ;
ROGERS, PAW .
HUMAN REPRODUCTION, 1993, 8 (10) :1632-1639
[9]   Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system [J].
Critchley, HOD ;
Wang, H ;
Kelly, RW ;
Gebbie, AE ;
Glasier, AF .
HUMAN REPRODUCTION, 1998, 13 (05) :1210-1217
[10]   TREATMENT WITH NORPLANT SUBDERMAL IMPLANTS INHIBITS SPERM PENETRATION THROUGH CERVICAL-MUCUS INVITRO [J].
CROXATTO, HB ;
DIAZ, S ;
SALVATIERRA, AM ;
MORALES, P ;
EBENSPERGER, C ;
BRANDEIS, A .
CONTRACEPTION, 1987, 36 (02) :193-201